Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of SII Typhoid Conjugate Vaccine versus Typbar in healthy infants 9 to 12 months old
PACTR202507569845862Phase 3Not yet recruiting
- Sponsor
- Serum Institute of India
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 3 trial in typhoid fever (2 arms), sponsored by Serum Institute of India. Primary endpoints: Immediate adverse events, Solicited adverse events and 2 more. Planned start Mar 2025; status: not yet recruiting.
02
Conditions
typhoid fever
Beyond the preview
Go deeper on PACTR202507569845862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507569845862.